Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
NCT02649647 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2023-12-06
Summary
Neoadjuvant chemoradiotherapy has been recommended as the standard preoperative treatment for locally advanced rectal cancer. However, preoperative radiotherapy increases the risk of bowel dysfunction after sphincter-preserving surgery, for which patients suffer from incontinence, urgency, and unpredictability defecation problems. Furthermore, preoperative chemoradiotherapy is a potential risk factor of anastomotic leakage and stenosis after rectal cancer surgery.
Unhealthy anastomosis, with both ends of injured bowel segments after pelvic radiation, is a major concern. When conventional surgical procedures would retain part of sigmoid colon that has been included in the radiation target, sphincter-preserving surgery with proximally extended resection margin could provide an intact proximal colon limb for the anastomosis.
It is not known yet whether proximally extended resection improves postoperative bowel function or anastomotic integrity for patients with rectal cancer after neoadjuvant chemoradiotherapy. The proposed study will compare sphincter-preserving surgery with and without proximally extended resection margin, to observe the postoperative bowel function, as well as the incidence of anastomotic complication. This study will examine a new surgical strategy, which potentially benefits the patients undergoing neoadjuvant chemoradiotherapy.
Conditions
Interventions
- PROCEDURE
-
Conventional resection
The conventional technique requests an excision of at least 10 cm of bowel proximal to the tumor, and the sigmoid colon is anastomosed to the rectum or anus. A defunctioning ileostomy is routinely performed.
- PROCEDURE
-
Proximally extended resection
The modified technique requests an excision of the whole sigmoid colon and rectum proximal to the tumor, and the descending colon is anastomosed to the rectum or anus. A defunctioning ileostomy is routinely performed.
Sponsors & Collaborators
-
Shanghai Changzheng Hospital
collaborator OTHER -
Peking Union Medical College Hospital
collaborator OTHER -
Sixth Affiliated Hospital, Sun Yat-sen University
lead OTHER
Principal Investigators
-
Lei Wang, MD, PhD · Sixth Affiliated Hospital, Sun Yat-sen University
-
Hui Wang, M.D. · Sixth Affiliated Hospital, Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2024-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
NCT02860234 ·Status: COMPLETED
-
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
High Dose Radiotherapy for the Treatment of Rectal Cancer
NCT03541304 ·Status: COMPLETED
-
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 ·Status: NOT_YET_RECRUITING
-
Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer
NCT03466424 ·Status: RECRUITING
-
Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer
NCT00949273 ·Status: UNKNOWN
-
Reducing the Resection Range After Neoadjuvant Therapy for Locally Advanced Upper Rectal and Rectosigmoid Junction Cancers
NCT07038122 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer
NCT01648894 ·Status: COMPLETED ·Phase: PHASE3
-
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
NCT04558684 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery
NCT03009747 ·Status: UNKNOWN
-
Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT03042000 ·Status: UNKNOWN ·Phase: NA
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy
NCT02052921 ·Status: TERMINATED ·Phase: NA
-
A Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for Treating Low Rectal Cancer
NCT01985698 ·Status: COMPLETED ·Phase: NA
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT06542354 ·Status: COMPLETED ·Phase: NA
-
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
NCT02992886 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NCT01271192 ·Status: UNKNOWN ·Phase: NA
-
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
NCT01047969 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052 ·Status: NOT_YET_RECRUITING
-
Stoma Discharge Reinfusion After Sphincter Preservation for Middle and Low Rectal Cancer
NCT05461248 ·Status: COMPLETED ·Phase: NA